Trade Summary

3 days ago, Aftab Dana, serving as EVP, Research, Development at Exelixis, Inc. (EXEL), sold 47,918 shares at $44.50 per share, for a total transaction value of $2,132,351.00. Following this transaction, Aftab Dana now holds 621,941 shares of EXEL.

This sale represents a 7.00% decrease in Aftab Dana's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, February 24, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, February 26, 2026, 2 days after the trade was made.

Exelixis, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.